International Clinical Trial: Long-term follow-up study on the safety and efficacy of subjects who participated in the Phase 2 clinical trial (LSCD101_P2) of LSCD101 (autologous limbal-derived epithelial cell sheet) for patients with intractable limbal stem cell deficiency (LSCD)

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (KCT0012695) titled 'Long-term follow-up study on the safety and efficacy of subjects who participated in the Phase 2 clinical trial (LSCD101_P2) of LSCD101 (autologous limbal-derived epithelial cell sheet) for patients with intractable limbal stem cell deficiency (LSCD)' on Sept. 28.

Study Type: Observational Study

Study Design: Observational Study Model : Cohort, Time Perspective : Prospective, Enrollment : 10, Biospecimen Retention : Not collect nor Archive

Primary Sponsor: CLIPSBnC

Condition:

Diseases of the eye and adnexa

Recruitment Status: Recruiting

Phase: NA

Date of First Enrollment: 2026-08-14

Target Sample Size: 10 ...